2192 — Medlive Technology Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMid CapHigh Flyer

Annual cashflow statement for Medlive Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	37	105	69.9	135	253
Depreciation
Amortisation
Non-Cash Items	1.02	-1.75	15.7	17.3	12.7
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-14.6	2.63	-47.3	-84.2	-173
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities	28.2	111	44.4	77.2	102
Capital Expenditures	-2.43	-0.626	-1.97	-7.49	-32.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	0.639	-48.6	-3,578	-602
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2.43	0.013	-50.5	-3,586	-635
Financing Cash Flow Items	-0.296	-0.209	-0.535	-5.24	-8.16
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3.43	-2.83	3,792	-22.4	-133
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	22.4	108	3,732	-3,201	-603